Specialised Therapeutics Distributing Oncotype DX Breast Cancer Assay in Australia, New Zealand | GenomeWeb

NEW YORK (GenomeWeb News) – Biopharmaceutical firm Specialised Therapeutics Australia announced today a deal for the distribution of Genomic Health's Oncotype DX breast cancer assay in Australia and New Zealand.

Financial and other terms of the agreement, which took effect Jan. 1, were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.